Welcome to the MDS Patient Message Board Post New Thread

Welcome to the MDS Patient Message Board. We hope that you will find this to be a very valuable resource in your journey. We have recently revised the format of our forum to be much more user friendly and pleasing on the eyes. Let us know if you have any problems, or if you have additional suggestions on how we might further improve our site.

Geron

This topic has 1 reply, 2 voices, and was last updated 4 days, 13 hours ago by Site Admin.

Viewing 2 posts - 1 through 2 (of 2 total)

Author

Posts
March 3, 2023 at 9:14 am #59325

Joe Catalano
Participant

Has anyone heard ANYTHING? About this?
Imetelstat Provides Durable Transfusion Independence in Lower-Risk MDS
Jan 4, 2023
By Kristi Rosa

Significant and durable transfusion independence was achieved with imetelstat vs placebo in patients with lower-risk myelodysplastic syndromes who were relapsed, refractory, or ineligible for erythropoiesis-stimulating agents, meeting the primary and a key secondary end point of the phase 3 IMerge trial.

March 18, 2023 at 9:00 am #59332

Site Admin
Moderator

Hi Joe, Here is a recent press release on Imetelstat:
Geron Announces Positive Top-Line Results from IMerge Phase 3 Trial of Imetelstat in Lower Risk MDS

https://ir.geron.com/investors/press-releases/press-release-details/2023/Geron-Announces-Positive-Top-Line-Results-from-IMerge-Phase-3-Trial-of-Imetelstat-in-Lower-Risk-MDS/default.aspx
Author

Posts

Viewing 2 posts - 1 through 2 (of 2 total)

Register for an account, or login to post to our message boards. Click here.

You must be logged in to reply to this topic.

Welcome to the MDS Patient Message Board Post New Thread

Geron

Register for an account, or login to post to our message boards. Click here.

Login

Login

Login

Search Forums

Recent Topics

CONTACT US

MEMBER OF